Stargardt Disease clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, in progress, not accepting new patients
The purpose of this study is to determine if emixustat hydrochloride reduces the rate of progression of macular atrophy compared to placebo in subjects with Stargardt disease.
San Francisco, California and other locations